It may, however, also divert funding and attention away from promising
nonanimal alternatives for testing disease processes and drug treatments.
Then the race will be on to replace those five second - tier in vivo ecotoxicity tests involving quail, fish, frogs, and rats with high - throughput
nonanimal alternatives.